Federica Fogacci Presents The New ILEP Consensus Paper
Federica Fogacci, Young Fellow at European Atherosclerosis Society, shared on LinkedIn:
”Rethinking lipid management for stroke prevention – new ILEP Consensus Paper
Ischemic stroke accounts for ~66% of all strokes and is now the third leading cause of death worldwide – yet a large proportion of patients still have undiagnosed or undertreated lipid disorders, both before and after a cerebrovascular event.
Together with an amazing international team from the International Lipid Expert Panel (ILEP), in collaboration with the ESC Council on Stroke, we have just published a new consensus paper on lipid management for primary and secondary stroke prevention in Progress in Cardiovascular Diseases
What’s inside the paper?
- Why dyslipidaemia (including LDL-C and Lp(a)) is a causal driver of ischaemic stroke
- Clear, pragmatic LDL-C and apoB targets for patients at risk of stroke and for those with prior stroke/TIA
- A strong message in favour of early, intensive and often combination lipid-lowering therapy (statins + ezetimibe ± PCSK9 inhibitors, bempedoic acid, inclisiran) to close the huge treatment gap in real-world practice
- How to think about Lp(a), triglyceride-rich lipoproteins, and non-HDL-C in stroke prevention
- The ILEP-SMILE framework: simple lifestyle “tips for the healthy cerebrum” to integrate pharmacological and non-pharmacological prevention
Our message is simple – and fully implementable in everyday practice:
“Lower is better, earlier is better, and longer is better” for LDL-C and overall lipid management in patients at risk of stroke and after stroke.
Even partial, consistent implementation of these principles could translate into fewer strokes and better long-term outcomes for our patients.”
Read the full article here.
Article: Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP)
Authors: Maciej Banach, Peter P. Toth, Hyo-Jeong Ahn, Agata Bielecka-Dabrowa, Arrigo F.G. Cicero, Adrian Covic, Mayank Dalakoti, Carlos Escobar, Federica Fogacci, Dan Gaita, Laura Gaita, Jacek Jóźwiak, Gustavs Latkovskis, Joanna Lewek, George Ntaios, Boguslaw Okopień, Ivan Pećin, Daniel Pella, Peter E. Penson, Marco Proietti, Gregory Y.H. Lip

Stay updated on all scientific advances with Hemostasis Today.
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis
